EDITORIAL: "Cancer Free"- A Dangerous Phrase?

 

By Cheri Ambrose, Founder of the Male Breast Cancer Global Alliance

For more than a decade, Cheri Ambrose has been a relentless voice for a community too often left out of the cancer conversation: men with breast cancer. As the founder of the Male Breast Cancer Global Alliance (MBCGA), she has advocated for education, equality in care, and survivor visibility across genders. In doing so, she has heard thousands of stories from patients and families. But one phrase continues to concern her deeply—two words used too often, too casually, and in ways that may ultimately cause harm: "cancer free."

I remember the first time I heard a survivor say, “They told me I was cancer free. I thought that meant I was done.” Those two little words—cancer free—sound like victory. For patients who’ve endured the brutal rigors of diagnosis and treatment, hearing them feels like a badge of honor, a long-awaited release. But we need to ask: Are we misleading patients into a false sense of security?

Doctors often say it with good intentions: “Your scans are clear. You're cancer free.” But what does that actually mean?

Let me be perfectly clear: There is no universal cure for cancer. Not yet. We have treatments that remove tumors, eliminate cells, and put disease into remission. We have scans that come back clean. But calling someone “cancer free” suggests something permanent—a line in the sand that cancer will never cross again.

In reality, that line is often blurred. Cancer has a notorious ability to return, sometimes years or even decades after initial treatment. And yet, when a patient hears those two words, they may believe they’re “done.” That belief can become dangerous.

❝ I stopped going to follow-ups. I thought I didn’t need to. Nobody explained that 'cancer free' didn’t mean forever. ❞ — David S., male breast cancer survivor

At MBCGA, we’ve seen many patients—especially men—let their guard down after hearing those words. Some stop getting regular checkups. Some abandon medication protocols. Some go back to high-risk habits like smoking, poor diet, or chronic stress. Why? Because they believed cancer was behind them. And many felt blindsided when it came back.

In one study published in the Journal of Oncology Practice, 38% of cancer survivors misinterpreted “no evidence of disease” as being cured.¹ And recurrence is more common than most realize:

• 30% of early-stage breast cancer survivors will experience a recurrence.²

• Recurrence can happen 5–10 years or more after treatment.³

• For men with BRCA2 mutations, the risk of a second primary cancer increases with age and time.⁴

So what should we be telling patients instead?

We need to replace feel-good ambiguity with clear, compassionate truth. “Your scans are clear,” is a great start—but it should always be followed by, “we’ll continue monitoring, because this doesn’t mean you're cured, only that we see no evidence of active disease right now.”

That’s what the term NED—No Evidence of Disease—actually means. Not that cancer is gone forever. Not that it's impossible to return. Just that, for now, we can’t detect it. And vigilance is still essential.

❝ I was healthy, active, and back at work. Then the headaches started… the scan showed bone metastases. I didn’t know recurrence was even possible after five years. I wish someone had told me. ❞

— Mark T., MBCGA community member

Language matters. Survivors need honesty, not euphemisms. They deserve to be educated about what remission, surveillance, and secondary prevention mean.

In fact, many survivorship programs are now integrating "prehab" and "rehab" lifestyle plans, helping survivors stay physically, mentally, and emotionally strong—precisely because the fight doesn’t end at “cancer free.”

What Do These Terms Actually Mean?

A Brief Survivorship Glossary for Clarity

• Cancer Free: A non-clinical term often used informally; may suggest “cured,” though this is rarely accurate.

• No Evidence of Disease (NED): No detectable cancer at the time of testing. Not the same as cured.

• Remission: A decrease or disappearance of cancer signs and symptoms. Can be partial or complete.

• Recurrence: The return of cancer after a period of NED or remission, either in the same place or elsewhere in the body.

• Metastatic: Cancer that has spread to distant parts of the body. May occur long after initial diagnosis.

When we fail to define these words, we risk encouraging complacency instead of vigilance. That doesn’t mean we rob survivors of hope—far from it. It means we equip them to thrive in their survivorship journey with eyes wide open.

We’ve made incredible progress in early detection, advanced imaging, and treatment customization. At MBCGA, we advocate for tools like point-of-care ultrasound, genetic predisposition testing, and ongoing survivorship plans for male breast cancer patients. But none of that matters if the messaging to patients remains vague or misleading.

I’m not saying we shouldn’t celebrate milestones. Survivors deserve to ring bells, throw parties, and embrace life. But let’s make sure those celebrations are grounded in truth. Let’s make sure our joy doesn’t become denial.

Let’s stop saying “cancer free” like it’s a destination. It’s a moment—a powerful, hopeful moment—but not the end of the road.

For anyone who's heard those words: stay vigilant. Keep your appointments. Take care of your body. Understand your risk. And ask your doctor to be clear, not just comforting.

For providers: speak carefully. Clarify the terms. Empower your patients with knowledge, not illusion. And for all of us in advocacy: let’s keep pushing for a survivorship culture that’s not just about surviving—but staying aware, informed, and alive.

Cheri Ambrose is the founder of the Male Breast Cancer Global Alliance, a global advocacy group dedicated to raising awareness, advancing education, and fighting bias in breast cancer care for all genders. Learn more or share your story at www.mbcglobalalliance.org.

WE WELCOME YOUR FEEDBACK TO THIS EDITORIAL. EMAIL US AT: SUPPORT@MBCGA.ORG

---

 📌 Footnotes: (1.) Nekhlyudov, L., et al. (2009). Understanding of Cure Among Cancer Survivors. J Oncol Pract. 5(3): 124–128. (2.) American Cancer Society. (2023). Breast Cancer Recurrence. (3.) National Cancer Institute. (2022). Recurrence After Treatment. (4.) Kuchenbaecker, K.B., et al. (2017). Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA.

RECURRENCE PREVENTION SCANNING
By: Dr. Robert L. Bard
After cancer surgery, there are many preventive measures to support a safe and healthy recovery and to reduce the risk of recurrence. The AngioInstitute recommends standardizing a postop maintenance process called RECURRENCE PREVENTION SCANS. Through the use of 3D Doppler Ultrasound, post-cancer surgery patients can subscribe to a regular monitoring program to detect possible lesions and micro-tumors that may have fallen under the radar. Moreover, proactive monitoring can mitigate complications such as post-surgical Infections, recurring Pain, Swelling, neuropathy from nerve damage, Scarring, Fluid buildup or Blood clots. All this can be seen and scanned by a seasoned imaging specialist trained to support postop patient management.

See complete feature and video by:
- Male Breast Cancer Global Alliance
- Dr. Roberta Kline's video report: RECURRENCE EXPLAINED
- Survivor Mike Landesberg Interview

Disclaimer & Copyright Notice: The materials provided on this web-based article are copyrighted and the intellectual property of the publishers/producers (The MBC Global Alliance). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

The information provided in this article is a compiled report from public websites whose links are listed in the FOOTNOTES OR REFERENCE section and the statements and quotes included are from actual interviews by those whose names are stated who provided express consent to the publishing of this material.  This article is not meant to be used to diagnose, treat or advise others about what actions they should take with regard to any medical condition.  No one should undertake or discontinue any treatment as a result of what they read on our blogs. The publisher(s), editors or sponsors  are providing a strictly educational or editorial service and are not responsible for the diagnosis or treatment of any specific health needs. Writers and publishers are not liable for any damages or negative consequences from any treatment, action, application or preparation to any person(s) reading the information in this article or its thread. Readers with medical needs should obtain appropriate professional medical supervision. References are provided for any informational purposes only and do not constitute endorsement of any websites or other sources.

Juiced and Jeopardized: How Hormone Abuse Fuels Male Breast Cancer and Broader Malignancies

Written by: Lennard M. Goetze, Ed.D / Nancy Chu, PhD

Introduction: Breaking the Silence on Male Hormone Use and Cancer

Male breast cancer (MBC) represents a small yet growing part of the global cancer burden—accounting for approximately 1% of the 1.67 million breast cancer cases diagnosed annually worldwide¹. That translates to roughly 20,000 new cases per year, with a lifetime risk of about 1 in 800 men¹. This rarity, combined with a cultural stigma, often obscures warning signs until advanced stages. Added to that danger is a booming subculture of “juicing”—the use of anabolic androgenic steroids (AAS), testosterone, and growth hormones to sculpt larger muscles and youthful physiques. Despite gym culture glorifying “pump,” mounting evidence indicates that these potent hormones may elevate the risk not just of MBC, but other cancers including prostate, liver, and skin malignancies. This article explores how hijacking the endocrine system through excess hormone intake elevates cancer risk in men—and calls for greater awareness before the next workout goes too far.

Understanding Male Breast Cancer: Beyond the X Chromosome

Male breast cancer often involves hormone-sensitive pathways similar to female breast cancer. About 80–95% of MBC tumors express androgen receptors (AR), while most also have estrogen receptors (ERα)—opening the door to hormonal carcinogenesis². Genetic risk factors play a role: BRCA2 mutations appear in approximately 12% of MBC cases, compared to 5% in women, while BRCA1 mutations are rare (~1%)¹. Other conditions such as Klinefelter syndrome, liver cirrhosis, and testicular dysfunction increase MBC risk by disrupting normal hormonal balance—especially when estrogen levels become disproportionately high¹.

"Juicing" and Hormonal Carcinogenesis: Busting the Risks

“Juicing” refers to the non-medical use of high-dose AAS, testosterone, and other hormones to build muscle. Often ingested at 10–100× therapeutic doses, taken cyclically or stacked with multiple compounds, these protocols radically alter the body’s hormone milieu³.

1. AAS and Male Breast Cancer
   Aromatization—where testosterone converts into estrogen—rises directly with high-dose AAS use. Drugs like nandrolone and stanozolol have been shown in vitro to stimulate estrogen-sensitive breast cancer cell lines, increasing ER–dependent mitogenic signals and cyclin D-mediated proliferation⁴. While large-scale observational data are limited, associations between anabolic steroid use, gynecomastia (male breast growth), and potential breast tumorigenesis are well documented⁵. The off-label use of breast cancer medications like tamoxifen and Arimidex by bodybuilders to mitigate these effects further illustrates the perceived risk⁶.

2. 
   Juicing and Broader Cancer Risk
   Some cohort studies—such as one involving over 1,000 Danish fitness-center users followed for over a decade—found no statistically significant increase in overall cancer incidence (IRR 1.05; 95% CI: 0.55–1.81), and no breast or prostate cancer cases among steroid users. However, the same study reported a markedly higher post-diagnosis mortality rate in the androgen-using group (HR 3.07; 95% CI: 1.35–7.00)⁷.

   Beyond breast and prostate, high testosterone has been linked to increased melanoma risk in men, with a large UK Biobank study suggesting a direct biological association⁸. Additionally, the International Agency for Research on Cancer classifies AAS as “probably carcinogenic to humans” (Group 2A)⁹.

3. Mechanisms: Hormones, Receptors, and DNA Damage

   • Estrogen receptor activation: Elevated estrogen during AAS use can stimulate ERα pathways, increasing cell cycle proliferation (e.g., cyclin D1 overexpression) and reducing apoptosis⁴.

   • Androgen receptor overdrive: AR is frequently overexpressed in MBC and other cancers. Excessive androgen binding may alter transcription networks that support tumor growth and evasion².

   • IGF‑1/growth hormone axis: Often elevated by exogenous hormones, this pathway promotes mitosis and cell survival—and high IGF‑1 levels are implicated in colorectal, breast, and prostate cancers⁴.

   • Immune suppression: Supra-physiological steroids and corticosteroids suppress immune function, potentially hampering tumor surveillance and enabling early cancer progression¹⁰.

---

Statistical Landscape & Real‑World Cases

Cancer Type	Incidence/Comments
Male Breast Cancer (MBC)	~20,000 new global cases/year (~1 in 800 men)¹
Androgen User Cohort	1,189 users vs 59,450 controls; IRR 1.05 overall, HR 3.07 post-diagnosis⁷
Melanoma (High Testosterone)	Linked to elevated risk in men⁸
AAS Carcinogenicity	Group 2A: probably carcinogenic to humans⁹

Case reports of liver adenomas, hepatic carcinoma, and rare male breast tumors continue to appear in medical literature. Although anecdotal, they highlight the real dangers of extreme hormone misuse.

---

Interventions and Moving Forward

• Stricter regulation: While the Designer Anabolic Steroid Control Act of 2014 expanded controlled substances lists, illicit gym-grade AAS remain easily accessible via black markets¹.

• Medical screening: Physicians should inquire about AAS use in men showing gynecomastia or early MBC signs; consider endocrine paneling and breast imaging.

• Harm reduction in gyms: Coaches and trainers can help reduce risks by discouraging off-label hormone use and encouraging natural muscle-building strategies.

• Public outreach: Awareness campaigns need to include male audiences about hormone risks—not just for heart health, but for cancer surveillance too.

---

Conclusion: When “Muscle” Meets Malignancy

The subculture of “juicing” may promise dramatic gains, but those gains come at a potentially deadly cost. Male breast cancer—once rare—is now rising in incidence worldwide, and although MBC has long been overlooked, it may be a sentinel warning of broader hormone-induced malignancies. The data may not fully capture the risk yet, but biological mechanisms are clear: excessive hormones fuel estrogenic and androgenic signaling, abet malignant growth, and impair the immune system’s ability to suppress aberrant cells. Even when cancer appears, outcomes post-diagnosis may be significantly worse in those with a history of AAS use.

Our cultural fascination with rapid transformation through endocrine manipulation demands urgent reevaluation. Until robust trials clarify the full risks, anecdotal signals—gynecomastia, hormone dependence, and deadly cancer outcomes—must not be ignored. Especially for men stepping onto the juicing path, awareness isn’t just power—it may be life-saving. Let’s pump iron, not hormones; build strength, not regrets.

---

Footnotes

1. Wikipedia contributors. (2025, June). Male breast cancer. Wikipedia. https://en.wikipedia.org/wiki/Male_breast_cancer

2. Shen, Y., et al. (2018). Characterizing steroid hormone receptor chromatin binding in male breast cancer. Nature Communications. https://doi.org/10.1038/s41467-018-04502-2

3. Wikipedia contributors. (2025, June). Anabolic steroid. Wikipedia. https://en.wikipedia.org/wiki/Anabolic_steroid

4. Penna, A., et al. (2017). Anabolic androgenic steroids and carcinogenicity: Focus on breast cancer mechanisms. Journal of Experimental Oncology.

5. Breastlink. (2025). Male Breast Cancer and Gynecomastia. https://www.breastlink.com/blog/male-breast-cancer-gynecomastia

6. Med News Today. (2024). Bodybuilders using tamoxifen and Arimidex to control gynecomastia.

7. Sørensen, H., et al. (2024). Excessive androgen exposure and cancer risk: A cohort study. Andrology Journal.

8. Cancer Research UK. (2021, March 31). New link between high testosterone in men and increased risk of melanoma. https://www.cancerresearchuk.org

9. International Agency for Research on Cancer (IARC). (2020). IARC Monographs on the Identification of Carcinogenic Hazards to Humans: Anabolic Steroids.

10. Antoni, M. H., Lutgendorf, S. K., Cole, S. W., et al. (2006). The influence of bio-behavioural factors on tumour biology: Pathways and mechanisms. Nature Reviews Cancer, 6(3), 240–248.

---

“DROP THE BIAS” is the campaign and battle cry of the Male Breast Cancer Global Alliance—a bold call to end the harmful misconception that breast cancer is a “women-only” disease. This bias in medicine, media, and society creates dangerous blind spots in care, leaving men misdiagnosed, undertreated, or ignored. It limits access to screening, support, and survivor recognition. But bias also lives within—men often avoid seeking help out of fear, stigma, or shame. “DROP THE BIAS” confronts this cultural and clinical oversight head-on, urging the world to recognize that men get breast cancer too. The campaign is not just about awareness—it’s about action. By challenging outdated assumptions, educating providers, empowering survivors, and opening dialogue, the Alliance aims to rewrite the narrative and save lives. “DROP THE BIAS” is a mission, a movement, and a message to all: equity in cancer care starts with truth.

Disclaimer & Copyright Notice: The materials provided on this web-based article are copyrighted and the intellectual property of the publishers/producers (The MBC Global Alliance). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

The information provided in this article is a compiled report from public websites whose links are listed in the FOOTNOTES OR REFERENCE section and the statements and quotes included are from actual interviews by those whose names are stated who provided express consent to the publishing of this material.  This article is not meant to be used to diagnose, treat or advise others about what actions they should take with regard to any medical condition.  No one should undertake or discontinue any treatment as a result of what they read on our blogs. The publisher(s), editors or sponsors  are providing a strictly educational or editorial service and are not responsible for the diagnosis or treatment of any specific health needs. Writers and publishers are not liable for any damages or negative consequences from any treatment, action, application or preparation to any person(s) reading the information in this article or its thread. Readers with medical needs should obtain appropriate professional medical supervision. References are provided for any informational purposes only and do not constitute endorsement of any websites or other sources.

What does it mean to be part of a MEDICAL ADVISORY BOARD?

By: Lennard M. Goetze, Ed.D

Joining a Medical Advisory Board (MAB) for a nonprofit organization like the Male Breast Cancer Global Alliance (MBCGA) is far more than an honorary position—it is a meaningful commitment to cancer advocacy, clinical excellence, and community impact. It represents the joining of skilled hands and brilliant minds to uplift a shared mission: to end the silence, address the bias, and advance the science around male breast cancer.

The role of an MAB member is multifaceted. These dedicated clinicians, researchers, and health experts become a vital extension of the organization’s purpose, bringing real-time expertise and evidence-based insight to support every facet of the Alliance’s work. From authoring educational content to contributing to public policy conversations, these advisors help ensure the MBCGA remains a trusted and medically credible resource for patients, caregivers, and advocates around the world.

At its core, the advisory board fuels knowledge. Members may collaborate to publish white papers, clinical commentaries, and research summaries. They review and validate health information distributed to the public, ensuring accuracy, clarity, and sensitivity. Their expertise helps to translate complex science into patient-centered resources that foster understanding and action.

Beyond publishing, advisory board members play a key role in collaboration. They serve as sounding boards for new programs and campaigns, providing clinical oversight to public health initiatives. Whether it's reviewing screening recommendations for high-risk men or participating in early detection campaigns, their guidance is instrumental in shaping the Alliance’s efforts and effectiveness.

Importantly, these professionals lend their voices in public forums. Advisory board members often serve as guest speakers for national seminars, media events, and webinars, offering powerful insights that bridge research and reality. By sharing clinical experiences and the latest updates in diagnosis, treatment, and survivorship, they amplify awareness and encourage informed decisions.

But being on a medical advisory board also comes with a deeper human responsibility. MBCGA is not just an advocacy group—it’s a growing family of survivors, caregivers, researchers, and clinicians bound together by compassion and a commitment to equity. Advisory board members provide reassurance, clarity, and hope to a community that too often feels overlooked in the breast cancer landscape. They serve as educators, but also as advocates—using their credentials to shine a light on the disparities and stigmas that keep men from getting the care they deserve.

Together, the MAB and MBCGA leadership work in synergy to build a living resource—a place where patients and their families can find expert guidance, clinical direction, and compassionate support. Every contribution—whether it's reviewing a medical blog, joining a research panel, or advising on screening protocols—ripples outward to affect lives directly.

In cancer advocacy, the clinical voice is vital. It elevates the mission from awareness to action. To join a medical advisory board like that of the Male Breast Cancer Global Alliance is to step into a legacy of leadership. It is to stand for evidence-based change, to guide a movement with integrity, and to make a lasting difference in how the world sees—and treats—male breast cancer.

For clinicians and researchers who believe in the power of purpose, this is more than a board—it’s a call to serve.

---

“DROP THE BIAS” is the campaign and battle cry of the Male Breast Cancer Global Alliance—a bold call to end the harmful misconception that breast cancer is a “women-only” disease. This bias in medicine, media, and society creates dangerous blind spots in care, leaving men misdiagnosed, undertreated, or ignored. It limits access to screening, support, and survivor recognition. But bias also lives within—men often avoid seeking help out of fear, stigma, or shame. “DROP THE BIAS” confronts this cultural and clinical oversight head-on, urging the world to recognize that men get breast cancer too. The campaign is not just about awareness—it’s about action. By challenging outdated assumptions, educating providers, empowering survivors, and opening dialogue, the Alliance aims to rewrite the narrative and save lives. “DROP THE BIAS” is a mission, a movement, and a message to all: equity in cancer care starts with truth.

Disclaimer & Copyright Notice: The materials provided on this web-based article are copyrighted and the intellectual property of the publishers/producers (The MBC Global Alliance). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

The information provided in this article is a compiled report from public websites whose links are listed in the FOOTNOTES OR REFERENCE section and the statements and quotes included are from actual interviews by those whose names are stated who provided express consent to the publishing of this material.  This article is not meant to be used to diagnose, treat or advise others about what actions they should take with regard to any medical condition.  No one should undertake or discontinue any treatment as a result of what they read on our blogs. The publisher(s), editors or sponsors  are providing a strictly educational or editorial service and are not responsible for the diagnosis or treatment of any specific health needs. Writers and publishers are not liable for any damages or negative consequences from any treatment, action, application or preparation to any person(s) reading the information in this article or its thread. Readers with medical needs should obtain appropriate professional medical supervision. References are provided for any informational purposes only and do not constitute endorsement of any websites or other sources.

Survivor Stories: Spotlight on DERRICK CAMERON

In 2009 I noticed a lump under on my chest while I was in the shower one day. This occurred during flag football season, so I figured it was a deep tissue bruise. After a couple of months when it didn’t go away, I decided to go to the doctor because it seemed to be getting larger. After the physician requested an ultrasound, then a biopsy, I was called for a return visit for my test results. I remember when the doctor told me I had cancer and by heart sank. I became terrified. How could a man get breast cancer? I am only 32 years old – does this happen to young people often?  My first question was, “How long do I have to live?” I had to get my thoughts together and figure out what the entire process would be. There were a lot of decisions made quickly, including finding an oncologist I would be comfortable with.

After initial consultations, I began my journey with my treatments in early 2010. I started with a double mastectomy to reduce the risk of the cancer returning on the opposite side of my chest. I followed my surgery with five months of chemotherapy treatments. Each treatment would last between 5 to 8 hours per visit. It was a very challenging time but I had great support from family and friends. Chemotherapy is extremely hard; there are so many things that occur in a person, and every person reacts differently to the treatment. Different side effects may occur in people who take chemotherapy, and the same side effect can have different reactions for patients. The first drug I took made me feel like I had ants crawling under the skin. The second drug affected my taste; as soon as the nurse began the injection, I tasting what seemed like metal, a very weird sensation. As if the effects from the first two drugs weren’t enough, the third—nicknamed “red devil”—was the hard one. Imagine a seven-inch long, one-inch diameter syringe full of a drug thick enough to be syrup.

The effects of dealing with cancer are great in magnitude. Mentally, I went through so many thoughts including questions about my family’s genetic code. Was this passed along in my family, and would I pass it along to my offspring? What will people say or think about me? How will people treat me? My short-term memory was affected as well.

The battle educated me about cancer in so many areas. I learned about the chemicals used to kill the cancer cells. I learned more about my strength and perseverance. I already had established my faith and grew up in the church. But cancer made me pray harder and trust more than I ever had, resulting in increased, everlasting faith. I quickly appreciated life and relationships more.

I learned more about relationships during my time of going through treatments then I may have learned in a decade. The entire journey was so powerful that I decided to write a book called “The Strength of a Man” so that it may help other men prepare for a winnable battle. I have also become a big advocate for men to go to the doctor – I sure have changed my perspective positively about annual checkups.

All the real men will take responsibility in taking care of their bodies and monitoring their health. I may not have been able to prevent getting breast cancer but having breast cancer did not make me any less of a man. In fact, breast cancer made me a better man.

IF YOU ARE A MALE BREAST CANCER SURVIVOR, WE WANT TO HEAR FROM YOU!  Contact us at support@mbcga.org or visit our website: www.mbcglobalalliance.org  

---

Knowing Your Genes Could Save Your Children: The Truth About Male Breast Cancer and Genetic Risk

Yeah, you read that right. Breast cancer doesn't care if you have pecs instead of breasts. It's time to kill the myth: male breast cancer is real, dangerous, and often overlooked. But here’s what most men don’t know: this isn't just about you—it's about your kids. Your genes carry the story, and if you don’t know your predisposition, you might be passing down a deadly risk to your sons and daughters.

GENETIC PREDISPOSITION TESTING FOR POTENTIAL HEREDITARY DISEASES: Genetic mutation can be inherited. When a specific cancer type is prevalent in one side of the family, the cancer is recognized as a FAMILIAL cancer. Most of them are caused by genetic mutation in a gene related to cancer susceptibility. In addition, a term called "family cancer syndrome" (or "hereditary cancer syndrome") is a rare disorder in which family members have an above-average chance of developing a certain type or types of cancer. Family cancer syndromes are caused by inherited genetic variants in certain cancer-related genes. It is reported that up to 10% of all cancer cases may be caused by inherited genetic mutation or changes. These are called CANCER PREDISPOSITION genes. Individuals who carry a mutant allele of these genes have an increased susceptibility to cancer. It is now widely identified that an accumulation of genetic or epigenetic alterations affect the conversion of normal cells to cancer cells. (See complete report)  This isn't just awareness. This is a wake-up call.

For more information about the MALE BREAST CANCER GLOBAL ALLIANCE PREDISPOSITION TESTING PROGRAM, contact us at: www.mbcglobalalliance.org or contact our hotline at: 516.522-0777

---

Breaking the Silence: How Dr. Robert Bard’s Imaging Innovations Are Revolutionizing Rare Cancer Detection Special Report – Diagnostic Frontlines | June 2025

In a healthcare landscape that often overlooks rare and aggressive cancers, one name continues to challenge the status quo with precision, passion, and purpose: Dr. Robert L. Bard, a globally recognized leader in cancer imaging. With a relentless mission to advance early detection and redefine standards of care, Dr. Bard is pioneering new technologies that are transforming how we fight cancer—especially the forms too often missed.

"Every cancer missed is a life put at risk," says Dr. Bard, whose practice in New York City has become a diagnostic epicenter for patients seeking clarity, second opinions, and advanced screening when conventional tools fall short. His work is especially focused on rare and understudied cancers, such as male breast cancer, sarcomas, and pediatric anomalies—cases where early detection is crucial, but frequently delayed or dismissed.

At the heart of his approach is a suite of non-invasive, real-time imaging modalities that push beyond the limitations of traditional scans. These include:

·        3D Doppler Ultrasound for blood flow analysis and angiogenesis mapping;

·        Elastography, a revolutionary tool to measure tissue stiffness and distinguish between benign and malignant lesions;

·        Thermographic Imaging, which visualizes abnormal heat patterns from inflammatory or vascular activity;

·        AI-integrated second opinion systems, offering patients and physicians critical review data for better-informed decisions.

Dr. Bard’s practice also champions active surveillance programs—helping patients monitor suspicious lesions over time without unnecessary procedures. “We’re not just finding cancers earlier,” he says. “We’re managing them smarter.”

He is currently spearheading multiple clinical research initiatives, working in collaboration with advocacy organizations and imaging device developers to validate emerging technologies for rare cancer diagnostics. His goal? To reshape outdated protocols and offer clinicians globally-accessible tools that support early, actionable findings.

“Imaging is our frontline weapon in saving lives,” Dr. Bard asserts. “My personal challenge is to bring this power to cancers that have been neglected for far too long.”

With every scan, every case, and every innovation, Dr. Robert Bard is proving that science, when driven by compassion and courage, can rewrite the future of cancer care.

---

“DROP THE BIAS” is the campaign and battle cry of the Male Breast Cancer Global Alliance—a bold call to end the harmful misconception that breast cancer is a “women-only” disease. This bias in medicine, media, and society creates dangerous blind spots in care, leaving men misdiagnosed, undertreated, or ignored. It limits access to screening, support, and survivor recognition. But bias also lives within—men often avoid seeking help out of fear, stigma, or shame. “DROP THE BIAS” confronts this cultural and clinical oversight head-on, urging the world to recognize that men get breast cancer too. The campaign is not just about awareness—it’s about action. By challenging outdated assumptions, educating providers, empowering survivors, and opening dialogue, the Alliance aims to rewrite the narrative and save lives. “DROP THE BIAS” is a mission, a movement, and a message to all: equity in cancer care starts with truth.

Disclaimer & Copyright Notice: The materials provided on this web-based article are copyrighted and the intellectual property of the publishers/producers (The MBC Global Alliance). It is provided publicly strictly for informational purposes within non-commercial use and not for purposes of resale, distribution, public display or performance. Unless otherwise indicated on this web based page, sharing, re-posting, re-publishing of this work is strictly prohibited without due permission from the publishers.  Also, certain content may be licensed from third-parties. The licenses for some of this Content may contain additional terms. When such Content licenses contain additional terms, we will make these terms available to you on those pages (which his incorporated herein by reference).The publishers/producers of this site and its contents such as videos, graphics, text, and other materials published are not intended to be a substitute for professional medical advice, diagnosis, or treatment. For any questions you may have regarding a medical condition, please always seek the advice of your physician or a qualified health provider. Do not postpone or disregard any professional medical advice over something you may have seen or read on this website. If you think you may have a medical emergency, call your doctor or 9-1-1 immediately.  This website does not support, endorse or recommend any specific products, tests, physicians, procedures, treatment opinions or other information that may be mentioned on this site. Referencing any content or information seen or published in this website or shared by other visitors of this website is solely at your own risk. The publishers/producers of this Internet web site reserves the right, at its sole discretion, to modify, disable access to, or discontinue, temporarily or permanently, all or any part of this Internet web site or any information contained thereon without liability or notice to you.

The information provided in this article is a compiled report from public websites whose links are listed in the FOOTNOTES OR REFERENCE section and the statements and quotes included are from actual interviews by those whose names are stated who provided express consent to the publishing of this material.  This article is not meant to be used to diagnose, treat or advise others about what actions they should take with regard to any medical condition.  No one should undertake or discontinue any treatment as a result of what they read on our blogs. The publisher(s), editors or sponsors  are providing a strictly educational or editorial service and are not responsible for the diagnosis or treatment of any specific health needs. Writers and publishers are not liable for any damages or negative consequences from any treatment, action, application or preparation to any person(s) reading the information in this article or its thread. Readers with medical needs should obtain appropriate professional medical supervision. References are provided for any informational purposes only and do not constitute endorsement of any websites or other sources.

2025 State Bill Proposal for Ultrasound Use for Male Breast Cancer

June 2025 – New York, NY — In a bold step toward medical equity, Dr. Lennard Goetze, national advocate for early detection and communications director of the Male Breast Cancer Global Alliance recently launched  a groundbreaking proposal for New York State Senators (and those from other states) that seek to improve cancer screening and prevention protocols.  These lawmakers are also anticipated to see the value of advanced ultrasound as the preferred diagnostic tool for male breast cancer. Backed by the Male Breast Cancer Global Alliance (MBCGA) and renowned diagnostic expert Dr. Robert Bard, the bill underscores the urgent need to revise outdated imaging protocols that have long failed male patients.

“This is not just a medical update—it’s a public health imperative,” says Dr. Goetze. “For too long, men with breast cancer have been an afterthought in our screening policies. It's time we change the narrative and the tools we use to save lives.”

WHY ULTRASOUND?
While mammography remains the standard screening modality for women, its use in men has repeatedly shown technical shortcomings. Male anatomy lacks the dense breast tissue and contours that mammograms were designed to image. Instead, high-resolution ultrasound offers a non-invasive, anatomically accurate, and highly sensitive alternative for detecting subdermal tumors in male breast tissue.

According to Dr. Robert Bard, a leading cancer imaging radiologist, “Ultrasound enables us to visualize abnormalities in the male breast with superior clarity. The male chest wall and flatter profile make mammograms less effective and, in many cases, inconclusive. This bill recognizes science—and common sense.”

LEGISLATIVE CALL TO ACTION
This proposed bill calls on legislators on a state-by-state level —particularly those who have championed breast screening laws for women—to now extend that same life-saving commitment to male patients facing breast cancer risk. The legislation seeks to:

    • Mandate insurance coverage for ultrasound as a reimbursable screening tool for men, especially those at high risk;

    • Designate ultrasound as the primary imaging modality for men with flat chest anatomy, where mammography is less effective;

    • Promote early detection initiatives tailored specifically to male breast cancer risk factors;

    • Support alignment with NCCN guidelines, which recommend regular clinical breast exams—and, in some cases, imaging—for men with BRCA1 or BRCA2 mutations.

By closing this diagnostic and policy gap, the bill affirms a broader commitment to equitable cancer care and timely detection for all.

With growing survivor testimony and increasing public support, the legislation is part of a national momentum to address gender bias in cancer detection.

Cheri Ambrose, co-founder of the MBCGA, adds: “This bill is a turning point for advocacy. It tells men everywhere that their lives matter. That their health matters. And that science is finally catching up.”

MALE BREAST CANCER: A SILENT CRISIS
Male breast cancer accounts for approximately 1% of all breast cancer cases, yet men are often diagnosed at more advanced stages. This delay stems from two key barriers: lack of awareness and inadequate screening tools. Many men are unaware they are at risk—particularly those with a family history or BRCA1/BRCA2 genetic mutations—and insurance coverage for imaging is inconsistent at best. 

Dr. Goetze’s proposal speaks directly to this gap. “When we delay diagnosis, we limit outcomes. If we want to change survivorship rates, we must enable early, accurate detection for men—starting with insurance-covered ultrasound screening.”

A BROADER VISION FOR MEN’S HEALTH
The bill aims to raise public awareness about the clinical advantages of ultrasound use, while promoting the message that breast cancer is not just a woman’s disease. Through collaboration with advocacy groups, clinicians, and cancer survivors, Dr. Goetze and his allies seek to dismantle stigma, encourage open dialogue, and improve access to preventive care for all. Dr. Goetze’s leadership stems from his deep commitment to health equity. As a clinical researcher, an educator and a voice for underserved patient populations, his proposal champions both clinical accuracy and human compassion.

JOIN THE MOVEMENT
This initiative is currently in pursuit of State Senate committee review. Dr. Goetze, the MBCGA, and allied medical leaders urge the public to get involved:

• Contact your legislators to express support;

• Use the hashtag #UltrasoundForMen to spread awareness;

• Share survivor stories and advocate for male-inclusive screening policy.

For more information or to support this campaign, visit www.MBCGlobalAlliance.org or contact the Office of Dr. Lennard Goetze @ 516-522-0777

---

A Unified Front Against Male Breast Cancer: Advocates ULTRASOUND Diagnostics, and a Lifesaving Bill

As the conversation around men’s health gains overdue momentum, a powerful coalition of medical pioneers and advocacy leaders has emerged to drive transformative change—starting with a new proposal to designate ultrasound as the primary screening modality for male breast cancer.

At the center of this movement is Cheri Ambrose, founder of the Male Breast Cancer Global Alliance (MBCGA), who has spent over a decade giving voice to the often-silent epidemic of male breast cancer. Her mission has always been clear: equality in care, visibility in diagnosis, and respect for the men and families impacted by this disease.

“Men deserve to be seen, heard, and protected,” says Ambrose. “This bill is not just a diagnostic update—it’s a declaration that male breast cancer matters. It’s a chance to save lives with the right tools, at the right time.”

This advocacy now intersects with science through the work of Dr. Robert L. Bard, internationally recognized radiologist and imaging expert, who was recently appointed Chair of Clinical Diagnostics for the MBCGA. A pioneer in using high-resolution, Doppler-based ultrasound imaging to detect cancers in men, Dr. Bard brings decades of expertise in early detection to the legislative table. “Male anatomy demands a different approach,” explains Dr. Bard. “Ultrasound is not just an option—it is the most precise and practical solution for male breast screening. I’ve seen it save lives.”

His leadership in developing non-invasive diagnostic protocols has reshaped standards in imaging across multiple cancer types. With Dr. Bard’s appointment, the MBCGA’s mission gains a powerful clinical dimension, ensuring that real science drives real change.

Together, Ambrose and Bard represent the perfect alliance of advocacy and innovation. Their unified voice, amplified through this bill, signals a new era in cancer care—where male patients are no longer overlooked, and where the right diagnosis can happen early enough to make all the difference.

---

“DROP THE BIAS” is the campaign and battle cry of the Male Breast Cancer Global Alliance—a bold call to end the harmful misconception that breast cancer is a “women-only” disease. This bias in medicine, media, and society creates dangerous blind spots in care, leaving men misdiagnosed, undertreated, or ignored. It limits access to screening, support, and survivor recognition. But bias also lives within—men often avoid seeking help out of fear, stigma, or shame. “DROP THE BIAS” confronts this cultural and clinical oversight head-on, urging the world to recognize that men get breast cancer too. The campaign is not just about awareness—it’s about action. By challenging outdated assumptions, educating providers, empowering survivors, and opening dialogue, the Alliance aims to rewrite the narrative and save lives. “DROP THE BIAS” is a mission, a movement, and a message to all: equity in cancer care starts with truth.

June is Men’s Health Month: Get Awareness about MEN'S BREAST CANCER!

June marks Men’s Health Month, a time to challenge outdated beliefs and confront the lesser-known truth: men can develop breast cancer too. Although rare, male breast cancer is real — and often underdiagnosed. Many men are unaware they’re at risk, leading to delays in detection and treatment. Common signs include lumps, skin dimpling, nipple changes, or discharge. Recognizing these symptoms early can make all the difference.

At the Male Breast Cancer Global Alliance (MBCGA), we’re committed to bringing male breast cancer out of the shadows. We support men facing this disease, amplify survivor voices, and connect patients with cutting-edge care and global research. Our mission is to eliminate stigma, promote early diagnosis, and push for equity in treatment.

Men at higher risk — including those with BRCA mutations, family history, hormonal imbalances, or environmental toxin exposure — should speak with their doctors and consider regular screenings. Firefighters, veterans, and industrial workers are particularly vulnerable.

Let’s end the myth that breast cancer is only a women’s issue. It’s time to speak up, get checked, and protect our men. This Men’s Health Month, we urge every man to take charge of his health. Awareness leads to action. Action leads to survival.

Get informed. Get checked. Get involved. Visit www.mbcglobalalliance.org to learn more.

“DROP THE BIAS” is the campaign and battle cry of the Male Breast Cancer Global Alliance—a bold call to end the harmful misconception that breast cancer is a “women-only” disease. This bias in medicine, media, and society creates dangerous blind spots in care, leaving men misdiagnosed, undertreated, or ignored. It limits access to screening, support, and survivor recognition. But bias also lives within—men often avoid seeking help out of fear, stigma, or shame. “DROP THE BIAS” confronts this cultural and clinical oversight head-on, urging the world to recognize that men get breast cancer too. The campaign is not just about awareness—it’s about action. By challenging outdated assumptions, educating providers, empowering survivors, and opening dialogue, the Alliance aims to rewrite the narrative and save lives. “DROP THE BIAS” is a mission, a movement, and a message to all: equity in cancer care starts with truth.

---

PHOTO INDEX

Click to enlarge

From our award-winning poster (above), meet nine of our dads who sent us pix from their latest Father’s Day celebration. Check out their stories in our website. These courageous men (among so many others) are more than survivors—they are warriors, role models, and living proof that early detection saves lives. 

(1) Ron Whittecar (2) Marc Ruiz (3) Paul Heying Jr (4) Troy Flint (5) Keith Parker (6) Reuben Board (7) Michael Landesberg (8) Jeff Landin (9) Jason Esquerra 

Each photo captures a story of strength: dads surrounded by family, celebrating life, resilience, and the power of support. From backyards to brunch tables, these moments reflect joy reclaimed after a life-changing diagnosis of male breast cancer. Through treatment, recovery, and advocacy, these fathers now inspire others to take charge of their health and raise awareness that men get breast cancer too. We honor them and all DADS this Father’s Day and thank them for standing proudly with the Male Breast Cancer Global Alliance.

---

A WORD FROM THE DOC

Father’s Day and June’s Men’s Health Month are more than annual reminders to honor the men in our lives—they’re critical moments to spark life-saving conversations. As a cancer diagnostic specialist, I’ve seen firsthand how Male Breast Cancer (MBC) continues to fly under the radar. It’s rare, but it’s very real. And too often, it’s caught late because men don’t believe it can happen to them.

MBC is not just a footnote in men’s health—it’s a serious and rising concern, especially among those with family histories, BRCA mutations, or occupational toxic exposures. That’s why being proactive is everything. If you're a man—or someone who loves one—take the first step today. Get Checked! Do a clinical breast exam. Talk to your doctor. And if you have a family history of breast or ovarian cancer, ask about genetic predisposition testing. Identifying a risk early can lead to regular monitoring and even prevention.

Men’s health is not just about muscles or heart disease—it’s about awareness, action, and knowing your body. Let’s rewrite the script on MBC, together.

—

Robert L. Bard, MD

Chair of Clinical Diagnostics / www.MBCScan.com

Advisory Board Member, Male Breast Cancer Global Alliance